Clinical Trial Update: Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT [EARLY_Phase 1]

View source ↗

Summary

An early-phase study update on detecting integrin αvβ6 with PET/CT in patients with idiopathic pulmonary fibrosis, primary sclerosing cholangitis, and COVID-19 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Idiopathic Pulmonary Fibrosis
• Sclerosing Cholangitis

Snippet

Sponsor: Stanford University | Conditions: Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis | EARLY_Phase 1 | Status: COMPLETED